SeaStar Medical Holding Co. (NASDAQ:ICUCW – Get Free Report) was the target of a large decline in short interest in September. As of September 30th, there was short interest totaling 3,721 shares, a decline of 44.7% from the September 15th total of 6,726 shares. Based on an average daily trading volume, of 3,588 shares, the short-interest ratio is presently 1.0 days.
SeaStar Medical Price Performance
NASDAQ ICUCW traded down $0.00 during trading hours on Thursday, reaching $0.02. The company’s stock had a trading volume of 10,485 shares, compared to its average volume of 72,334. SeaStar Medical has a fifty-two week low of $0.01 and a fifty-two week high of $0.07. The company’s 50-day moving average is $0.02 and its two-hundred day moving average is $0.02.
SeaStar Medical Company Profile
SeaStar Medical Holding Corporation is a medical technology company focused on developing extracorporeal therapies that target systemic inflammation in critically ill patients. Its principal technology is the Selective Cytopheretic Device (SCD), a blood-purification device designed to selectively reduce the activity of pro-inflammatory immune cells while preserving other immune functions.
The SCD is being developed for use in intensive-care settings, including the treatment of acute kidney injury and other conditions associated with excessive inflammation.
Featured Stories
- Five stocks we like better than SeaStar Medical
- ASML Can’t Keep Up With AI Demand—Why That’s a Good Thing
- Enovix’s 100,000-Battery Drone Order Sets Up a Test of Its Production Plans
- AMD’s Support Could Help Fermi Stock Overcome Its Biggest Hurdle
- Beyond the GPU: Credo Paves the Next AI Data Superhighway
Receive News & Ratings for SeaStar Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SeaStar Medical and related companies with MarketBeat.com's FREE daily email newsletter.
